HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury
Advanced Science · 2025-05 · 12 (19)
DOI: 10.1002/advs.202410764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.03.2025. Verfasst von Ling Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Renal Insufficiency, Chronic, Kidney, Acute Kidney Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic Kidney Disease (CKD) is a global health challenge, with acute kidney injury (AKI) from ischemia‐reperfusion injury (IRI) as a common cause. This study explored the role of Hepatocyte Nuclear Factor 3 alpha (HNF3α/FOXA1) in renal fibrosis and CKD after IRI. Kidney biopsy specimens from CKD patients and mouse models (IRI or unilateral ureteral obstruction) showed HNF3α upregulation in fibrotic kidneys, linked to renal function decline. Additional experiments demonstrated that deletion of HNF3α mitigated IRI‐induced renal fibrosis, and that overexpression of HNF3α led to increased fibrosis. Examination of the potential mechanism by transcriptome sequencing and CUT&Tag sequencing suggested that HNF3α promoted renal fibrosis by increasing the expression of the NCK associated protein 1 like (Nckap1l, formerly known as hematopoietic protein 1 [Hem1]), a vital component of the WAVE complex which plays a significant role in cytoskeletal regulation and cell migration. These results underscore the critical function of HNF3α in renal fibrosis following IRI, and also identify Nckap1l as a potential therapeutic target, thus opening new avenues for research and potential therapeutic interventions for CKD and renal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
- Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
- Jiangsu Key Laboratory of Early Development and Chronic Diseases Prevention in Children, Nanjing Medical University, Nanjing, 210029, China.
ORCID-Profile: Aihua Zhang
Förderung
- China Postdoctoral Science Foundation
- National Key R&D Program of China
- National Natural Science Foundation of China
- Key Projects of Jiangsu Province
- National Key Research and Development Program of China
Zitieren
APA
Hou, L., Guo, Y., Xu, S., Bai, M., Cao, W., Zhang, Y., Jia, Z., & Zhang, A. (2025). HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury. Advanced Science, 12(19). https://doi.org/10.1002/advs.202410764
Vancouver
Hou L, Guo Y, Xu S, Bai M, Cao W, Zhang Y, et al. HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury. Advanced Science. 2025;12(19). doi:10.1002/advs.202410764
BibTeX
@article{Hou2025,
author = {Hou, Ling and Guo, Yan and Xu, Shuang and Bai, Mi and Cao, Weidong and Zhang, Yue and Jia, Zhanjun and Zhang, Aihua},
title = {HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {19},
doi = {10.1002/advs.202410764}
}
EUVIMED